BAMBROVA Trademark

Trademark Overview


On Wednesday, April 1, 2020, a trademark application was filed for BAMBROVA with the United States Patent and Trademark Office. The USPTO has given the BAMBROVA trademark a serial number of 88856326. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2024. This trademark is owned by Bristol-Myers Squibb Company. The BAMBROVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical...
bambrova

General Information


Serial Number88856326
Word MarkBAMBROVA
Filing DateWednesday, April 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Wednesday, April 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 4, 2020NEW APPLICATION ENTERED
Tuesday, June 2, 2020ASSIGNED TO EXAMINER
Wednesday, June 3, 2020NON-FINAL ACTION WRITTEN
Wednesday, June 3, 2020NON-FINAL ACTION E-MAILED
Wednesday, June 3, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 27, 2021SOU TEAS EXTENSION RECEIVED
Monday, September 27, 2021SOU EXTENSION 1 FILED
Monday, September 27, 2021SOU EXTENSION 1 GRANTED
Wednesday, September 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 7, 2022SOU TEAS EXTENSION RECEIVED
Monday, March 7, 2022SOU EXTENSION 2 FILED
Monday, March 7, 2022SOU EXTENSION 2 GRANTED
Wednesday, March 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, September 6, 2022SOU EXTENSION 3 FILED
Tuesday, September 6, 2022SOU EXTENSION 3 GRANTED
Thursday, September 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 27, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 27, 2023SOU EXTENSION 4 FILED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 27, 2023SOU EXTENSION 4 GRANTED
Wednesday, March 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 26, 2023SOU EXTENSION 5 FILED
Tuesday, October 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 4, 2023SOU EXTENSION 5 GRANTED
Thursday, October 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, May 6, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, September 26, 2023SOU TEAS EXTENSION RECEIVED